Bio-Techne (TECH) Earnings Date, Estimates & Call Transcripts $68.68 +0.31 (+0.45%) (As of 10/25/2024 08:57 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateOct. 30Before Market OpensConfirmedActual EPS (Aug. 7) $0.49 Consensus EPS (Aug. 7) $0.49 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTECH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TECH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Bio-Techne Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242$0.40$0.44$0.42Q2 20242$0.40$0.49$0.45Q3 20244$0.42$0.55$0.47Q4 20244$0.47$0.57$0.50FY 202412$1.69$2.05$1.83Q1 20252$0.34$0.46$0.40Q2 20252$0.34$0.49$0.42Q3 20252$0.48$0.56$0.52Q4 20252$0.57$0.57$0.57FY 20258$1.73$2.08$1.91Q1 20261$0.44$0.44$0.44Q2 20261$0.45$0.45$0.45Q4 20261$0.62$0.62$0.62TECH Earnings Date and InformationBio-Techne last released its quarterly earnings data on August 7th, 2024. The biotechnology company reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. The firm had revenue of $306.10 million for the quarter, compared to the consensus estimate of $306.49 million. Its revenue for the quarter was up 1.6% on a year-over-year basis. Bio-Techne has generated $1.26 earnings per share over the last year ($1.26 diluted earnings per share) and currently has a price-to-earnings ratio of 66.0. Earnings for Bio-Techne are expected to grow by 18.24% in the coming year, from $1.70 to $2.01 per share. Bio-Techne has confirmed that its next quarterly earnings report will be published on Wednesday, October 30th, 2024. Bio-Techne will be holding an earnings conference call on Wednesday, October 30th at 9:00 AM Eastern. Interested parties can register for or listen to the call. or dial in at 412-317-6671 with passcode "13749405". Read More Bio-Techne Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/30/2024(Confirmed)------- 8/7/2024Q4 2024$0.49$0.49-$0.73$306.49 million$306.10 million 5/1/2024Q3 2024$0.45$0.48+$0.03$0.57$292.36 million$303.43 million 2/1/2024Q2 2024$0.36$0.33($0.03)$0.49$277.48 million$272.60 million 10/31/2023Q1 2024$0.39$0.35($0.04)$0.39$289.81 million$276.94 million 8/8/2023Q4 2023$0.49$0.56+$0.07$0.65$304.71 million$301.32 million 5/3/2023Q3 2023$0.48$0.53+$0.05$0.51$298.55 million$294.15 million Election Year's Hidden Stock Winners (Ad)In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link.2/2/2023Q2 2023$0.41$0.38($0.03)$0.45$289.98 million$271.58 million 11/1/2022Q1 2023$0.41$0.36($0.05)$0.17$281.89 million$269.66 million 8/4/2022Q4 2022$0.4650$0.47+$0.0050$2.25$287.04 million$288.30 million 5/4/2022Q3 2022$0.4375$0.49+$0.0525$2.44$279.27 million$290.40 million 2/1/2022Q2 2022$0.3975$0.40+$0.0025$1.26$266.57 million$269.30 million 11/1/2021Q3 2021$0.43$0.4575+$0.0275$1.43$254.37 million$257.72 million 8/5/2021Q2 2021$0.3675$0.4675+$0.10$2.97$247.00 million$259.03 million 5/6/2021Q1 2021$0.31$0.4475+$0.1375$2.10$228.57 million$243.55 million 2/1/2021Q4 2020$0.3425$0.4050+$0.0625$1.37$206.50 million$224.30 million 11/5/2020Q3 2020$0.2750$0.3575+$0.0825$1.47$185.04 million$204.20 million 8/4/2020Q2 2020$0.1425$0.25+$0.1075$0.26$165.70 million$175.83 million 4/30/2020Q1 2020$0.2875$0.3475+$0.06$1.52$182.32 million$194.70 million 2/4/2020Q2 2020$0.2825$0.27($0.0125)($1.40)$191.34 million$184.93 million 10/29/2019Q1 2020$0.23$0.2650+$0.0350$1.39$179.38 million$183.24 million Bio-Techne Earnings - Frequently Asked Questions When is Bio-Techne's earnings date? Bio-Techne has confirmed that its next quarterly earnings data will be published on Wednesday, October 30th, 2024. Learn more on TECH's earnings history. Did Bio-Techne beat their earnings estimates last quarter? In the previous quarter, Bio-Techne (NASDAQ:TECH) reported $0.49 earnings per share (EPS) to hit the analysts' consensus estimate of $0.49. Learn more on analysts' earnings estimate vs. TECH's actual earnings. How can I listen to Bio-Techne's earnings conference call? The conference call for Bio-Techne's latest earnings report can be listened to online. Listen to Conference Call How can I read Bio-Techne's conference call transcript? The conference call transcript for Bio-Techne's latest earnings report can be read online. Read Transcript How much revenue does Bio-Techne generate each year? Bio-Techne (NASDAQ:TECH) has a recorded annual revenue of $1.16 billion. How much profit does Bio-Techne generate each year? Bio-Techne (NASDAQ:TECH) has a recorded net income of $168.10 million. TECH has generated $1.26 earnings per share over the last four quarters. What is Bio-Techne's price-to-earnings ratio? Bio-Techne (NASDAQ:TECH) has a trailing price-to-earnings ratio of 66.04 and a forward price-to-earnings ratio of 40.40. The price/earnings-to-growth ratio is 5.05. What is Bio-Techne's EPS forecast for next year? Bio-Techne's earnings are expected to grow from $1.70 per share to $2.01 per share in the next year, which is a 18.24% increase. ` More Earnings Resources from MarketBeat Related Companies Agilent Technologies Earnings Results Mettler-Toledo International Earnings Results Illumina Earnings Results Waters Earnings Results Bio-Rad Laboratories Earnings Results Charles River Laboratories International Earnings Results Bruker Earnings Results Pacific Biosciences of California Earnings Results Harvard Bioscience Earnings Results Thermo Fisher Scientific Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat This page (NASDAQ:TECH) was last updated on 10/28/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredCountdown to Chaos begins WednesdayWill it be Trump or Harris? In an exclusive interview on Wednesday, October 30, at 8 p.m. ET, he’ll explain...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)27 of the world's brightest minds in crypto are gathering to reveal their top picks and predictions for the ma...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Bio-Techne Co. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
